Immediate Impact

2 by Nobel laureates 8 from Science/Nature 54 standout
Sub-graph 1 of 25

Citing Papers

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2021 Standout
2 intermediate papers

Works of X.‐Q. Mao being referenced

Association between Variants of Mast Cell Chymase Gene and Serum IgE Levels in Eczema
1998
Association between genetic variants of mast-cell chymase and eczema
1996

Author Peers

Author Last Decade Papers Cites
X.‐Q. Mao 168 308 88 166 20 529
Seblewongel Asrat 223 252 104 182 13 624
Masahiro Ogawa 137 166 106 84 31 600
Holger Petering 287 206 44 81 18 548
Pilar Palomino 249 112 148 190 19 563
F. Michael Melewicz 312 137 90 82 18 584
Harry A. Swedlund 184 244 57 194 14 628
Yihong Wang 335 230 41 78 11 641
Jason Xenakis 198 187 44 86 21 565
Yao‐Pi Hsu 88 153 66 146 13 487
Annemiek Dijkhuis 228 299 90 42 17 553

All Works

Loading papers...

Rankless by CCL
2026